1. Of the 89 medicines being developed here for heart disease,
how many are you willing to live without?
Heart disease is North Carolina's leading cause of death, killing 17,500 residents in 2007.
But there's new hope on the horizon.
North Carolina pharmaceutical and biotechnology companies are developing 89 of the 312 medicines
in development nationwide for heart disease and stroke.
Our state is helping keep up the momentum of drug discovery that has helped cut U.S. deaths
from these diseases by more than 25 percent between 1999 and 2005.
What could keep these promising new therapies from reaching patients?
Government policies that harm biopharmaceutical research and remove the incentives
to find new and better heart disease medicines.
We must not put roadblocks in front of the North Carolina's pharmaceutical and biotechnology companies
as they uncover the life-saving drugs of tomorrow.
Learn how the biopharmaceutical industry is bettering patient care at
www.phrma.org